Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16672265rdf:typepubmed:Citationlld:pubmed
pubmed-article:16672265lifeskim:mentionsumls-concept:C1416433lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C0521447lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C0023810lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C0063700lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C1120843lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C1564138lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C0040649lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C0040661lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C1705162lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:16672265lifeskim:mentionsumls-concept:C0205224lld:lifeskim
pubmed-article:16672265pubmed:issue4lld:pubmed
pubmed-article:16672265pubmed:dateCreated2006-5-4lld:pubmed
pubmed-article:16672265pubmed:abstractTextIndoleamine 2,3-dioxygenase (IDO) is induced by interferon (IFN)-gamma-mediated effects of the signal transducer and activator of transcription 1alpha (STAT1alpha) and interferon regulatory factor (IRF)-1. The induction of IDO can also be mediated through an IFN-gamma-independent mechanism, although the mechanism of induction has not been identified. In this study, we explored whether lipopolysaccharide (LPS) or several proinflammatory cytokines can induce IDO via an IFN-gamma-independent mechanism, and whether IDO induction by LPS requires the STAT1alpha and IRF-1 signaling pathways. IDO was induced by LPS or IFN-gamma in peripheral blood mononuclear cells and THP-1 cells, and a synergistic IDO induction occurred when THP-1 cells were cultured in the presence of a combination of tumor necrosis factor-alpha, interleukin-6 or interleukin-1beta. An electrophoretic mobility shift assay using STAT1alpha and IRF-1 consensus oligonucleotide probes showed no STAT1alpha or IRF-1 binding activities in LPS-stimulated THP-1 cells. Further, the LPS-induced IDO activity was inhibited by both p38 mitogen-activated protein kinase (MAPK) and nuclear factor-kappaB (NF-kappaB) inhibitors. These findings suggest that the induction of IDO by LPS in THP-1 cells is not regulated by IFN-gamma via recruitment of STAT1alpha or IRF-1 to the intracellular signaling pathway, and may be related to the activity of the p38 MAPK pathway and NF-kappaB.lld:pubmed
pubmed-article:16672265pubmed:languageenglld:pubmed
pubmed-article:16672265pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:citationSubsetIMlld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16672265pubmed:statusMEDLINElld:pubmed
pubmed-article:16672265pubmed:monthAprlld:pubmed
pubmed-article:16672265pubmed:issn0021-924Xlld:pubmed
pubmed-article:16672265pubmed:authorpubmed-author:IshiguroHiros...lld:pubmed
pubmed-article:16672265pubmed:authorpubmed-author:FujigakiSuwak...lld:pubmed
pubmed-article:16672265pubmed:authorpubmed-author:SaitoKuniakiKlld:pubmed
pubmed-article:16672265pubmed:authorpubmed-author:TakemuraMasao...lld:pubmed
pubmed-article:16672265pubmed:authorpubmed-author:SeishimaMitsu...lld:pubmed
pubmed-article:16672265pubmed:authorpubmed-author:FujigakiHidet...lld:pubmed
pubmed-article:16672265pubmed:authorpubmed-author:SudoKaoriKlld:pubmed
pubmed-article:16672265pubmed:issnTypePrintlld:pubmed
pubmed-article:16672265pubmed:volume139lld:pubmed
pubmed-article:16672265pubmed:ownerNLMlld:pubmed
pubmed-article:16672265pubmed:authorsCompleteYlld:pubmed
pubmed-article:16672265pubmed:pagination655-62lld:pubmed
pubmed-article:16672265pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:meshHeadingpubmed-meshheading:16672265...lld:pubmed
pubmed-article:16672265pubmed:year2006lld:pubmed
pubmed-article:16672265pubmed:articleTitleThe signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines.lld:pubmed
pubmed-article:16672265pubmed:affiliationDepartment of Informative Clinical Medicine, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu City, Gifu 501-1194.lld:pubmed
pubmed-article:16672265pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16672265lld:pubmed